Loading...
Globus Medical, Inc.
GMED•NYSE
Healthcare
Medical - Devices
$54.48
$1.19(2.23%)
Globus Medical, Inc. (GMED) Financial Performance & Income Statement Overview
Review Globus Medical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
60.62%
↑ 60.62%
Operating Income Growth
24.67%
↑ 24.67%
Net Income Growth
-16.19%
↓ 16.19%
Operating Cash Flow Growth
113.82%
↑ 113.82%
Operating Margin
10.73%
↑ 10.73%
Gross Margin
57.02%
↑ 57.02%
Net Profit Margin
7.39%
↑ 7.39%
ROE
4.55%
↑ 4.55%
ROIC
6.23%
↑ 6.23%
Globus Medical, Inc. (GMED) Income Statement & Financial Overview
Review Globus Medical, Inc.'s (GMED) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $657.29M | $625.71M | $629.69M | $606.67M |
| Cost of Revenue | $263.44M | $300.59M | $289.75M | $271.16M |
| Gross Profit | $393.86M | $325.11M | $339.94M | $335.50M |
| Gross Profit Ratio | $0.60 | $0.52 | $0.54 | $0.55 |
| R&D Expenses | $33.41M | $35.38M | $37.70M | $44.67M |
| SG&A Expenses | $253.48M | $240.74M | $238.12M | $248.71M |
| Operating Expenses | $333.58M | $276.12M | $275.82M | $293.38M |
| Total Costs & Expenses | $597.02M | $576.71M | $565.57M | $564.54M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $775000.00 | $2.33M | $1.89M |
| Depreciation & Amortization | $68.23M | $66.95M | $63.59M | $55.26M |
| EBITDA | $145.28M | $115.94M | $113.50M | $138.46M |
| EBITDA Ratio | $0.22 | $0.19 | $0.18 | $0.23 |
| Operating Income | $60.27M | $48.10M | $64.13M | $42.13M |
| Operating Income Ratio | $0.09 | $0.08 | $0.10 | $0.07 |
| Other Income/Expenses (Net) | -$35.61M | $8.93M | -$2.04M | -$16.55M |
| Income Before Tax | $24.67M | $57.03M | $47.58M | -$8.56M |
| Income Before Tax Ratio | $0.04 | $0.09 | $0.08 | -$0.01 |
| Income Tax Expense | -$1.84M | $5.20M | $15.82M | -$1.44M |
| Net Income | $26.50M | $51.84M | $31.76M | -$7.12M |
| Net Income Ratio | $0.04 | $0.08 | $0.05 | -$0.01 |
| EPS | $0.19 | $0.38 | $0.23 | -$0.05 |
| Diluted EPS | $0.19 | $0.38 | $0.23 | -$0.05 |
| Weighted Avg Shares Outstanding | $136.73M | $135.62M | $135.19M | $135.36M |
| Weighted Avg Shares Outstanding (Diluted) | $139.71M | $138.06M | $136.98M | $135.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan